Ann: Voluntary Suspension, page-277

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 277 Last

Share
Profile

Follow
MightyChina

388 Posts.

04/08/17

20:53

Post #: 26304789
Share

Originally posted by Ciao ↑

Thanks Doc for your opinion .
Resapp website: Diagnosis of respiratory disease is one of the most common outcomes from visiting a doctor. Respiratory diseases can be caused by inflammation, bacterial infection or viral infection of the respiratory tract. Diseases caused by inflammation include chronic conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). Acute conditions, caused by either bacterial or viral infection, can affect either the upper or lower respiratory tract. Upper respiratory tract infections include common colds while lower respiratory tract infections include diseases such as pneumonia. Other infections include influenza, acute bronchitis and bronchiolitis.
Used as a clinical aid during emergency room or general clinic consultations, ResApp’s instant, low cost and accurate diagnostic test offers many benefits over the traditional diagnostic pathway. For pneumonia in particular, Resapp’s test costs significantly less than an x-ray and follow-up consultation, and provides accurate results faster which enables physicians to initiate appropriate therapy immediately.
Do you agree yes/no?
What draws me to Resapp besides wanting to make a profit from the shares is really quite simple.
Traditional Medical Practice costs too much – not everyone can afford it, becoming increasingly obvious that families/individuals are ditching health insurance.
Governments can’t afford ever increasing health costs.
Cheaper alternatives need to be explored – Telehealth!
Given a choice consumers/patients would prefer to pay $10 for Resapp diagnosis if it provides the same accuracy as a traditional diagnosis with all the add ons.
Not everyone has close access to medical facilities not only third world issue.
The majority of doctors will not tell you what the battery of referrals/tests will cost, nor do they care, they just want to cover their liability issues if proven negligent.
Agree some Rapers are too protective off their patch and too many Doctors can’t see the freight train coming.

Expand

it is not a patch to protect, rather mortality and morbidity that drives medical decision making

there is way too much money centered mentation here on HC for comfort with this company

to me, that's more likely patch protection. History shows how such thinking ends.

Last edited by MightyChina: 04/08/17

RAP Price at posting: 31.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CU6

Clarity progresses SECuRE trial with positive safety results

MTM

Forget gallium: MTM says it's extracted gold from e-waste

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

BRX

Belararox to grow copper footprint in Botswana with 4,286 square km tenure

3 stocks with antimony news on Thursday

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept

NEC

Nine Entertainment announces its CEO is stepping down – on an ex-divvy day

ASX Market Open: Local bourse to trade green | Thursday September 12